Cayman: FDA recall - Ranitidine Products

From Health Services Authority
Please
be advised, The FDA has ordered a recall of all
Ranitidine products,
due to manufacturing issues.
Patients
taking any form of prescription Ranitidine (tablets or liquids) have
been asked to discontinue and contact their doctor for an
alternative.
Persons
have also been advised not to purchase over-the-counter Ranitidine
products (e.g. Zantac®).
Published April 3, 2020
Join the discussion — please keep to our Community Guidelines.